Aberrant ceRNA activity drives lung cancer

Cell Research

Volumn 24, Issue 3, 2014, Pages 259-260

  Tay, Yvonne ^a   Karreth, Florian A ^a   Pandolfi, Pier Paolo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN;

ANIMAL; DISEASE COURSE; GENETICS; HUMAN; LUNG TUMOR; PATHOLOGY;

ANIMALS; DISEASE PROGRESSION; HMGA2 PROTEIN; HUMANS; LUNG NEOPLASMS;

EID: 84897645765     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2014.21     Document Type: Article

References (9)

1. Salmena L, Poliseno L, Tay Y, et al. Cell 2011; 146:353-358.
2. Tay Y, Rinn J, Pandolfi PP. Nature 2014; 505:344-352.
3. Kumar MS, Armenteros-Monterroso E, East P, et al. Nature 2014; 505:212-217.
4. Mayr C, Hemann MT, Bartel DP. Science 2007; 315:1576-1579.
5. Kumar MS, Erkeland SJ, Pester RE, et al. Proc Natl Acad Sci USA 2008; 105:3903-3908.
6. Cazalla D, Yario T, Steitz JA. Science 2010; 328:1563-1566.
7. Ala U, Karreth FA, Bosia C, et al. Proc Natl Acad Sci USA 2013; 110:7154-7159.
8. Rice SJ, Lai SC, Wood LW, et al. J Biol Chem 2013; 288:16348-16360.
9. Zhu C, Li J, Cheng G, et al. Mol Cell Biochem 2013; 379:69-75.